Canada Markets closed

Nuvo Pharmaceuticals Inc. (MRVFF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.45700.0000 (0.00%)
At close: 09:30AM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.30
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 31.2500
52 Week Low 30.4200
50-Day Moving Average 30.5430
200-Day Moving Average 30.7061

Share Statistics

Avg Vol (3 month) 31.91k
Avg Vol (10 day) 3830
Shares Outstanding 511.39M
Implied Shares Outstanding 6N/A
Float 88.93M
% Held by Insiders 14.71%
% Held by Institutions 115.35%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21354:1000
Last Split Date 3Mar 06, 2016

Financial Highlights

Currency in CAD.

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022


Profit Margin -4.28%
Operating Margin (ttm)18.49%

Management Effectiveness

Return on Assets (ttm)5.97%
Return on Equity (ttm)-29.24%

Income Statement

Revenue (ttm)71.28M
Revenue Per Share (ttm)6.26
Quarterly Revenue Growth (yoy)5.90%
Gross Profit (ttm)44.46M
Net Income Avi to Common (ttm)-3.05M
Diluted EPS (ttm)-1.6820
Quarterly Earnings Growth (yoy)99.90%

Balance Sheet

Total Cash (mrq)28.58M
Total Cash Per Share (mrq)2.51
Total Debt (mrq)94.88M
Total Debt/Equity (mrq)1,078.14
Current Ratio (mrq)2.17
Book Value Per Share (mrq)-0.52

Cash Flow Statement

Operating Cash Flow (ttm)15.82M
Levered Free Cash Flow (ttm)7.26M